- PMID: 38555299
- DOI: 10.1038/s41398-024-02877-0
Abstract
Chronic stress is a major risk factor for neuropsychiatric conditions such as depression. Adult hippocampal neurogenesis (AHN) has emerged as a promising target to counteract stress-related disorders given the ability of newborn neurons to facilitate endogenous plasticity. Recent data sheds light on the interaction between cannabinoids and neurotrophic factors underlying the regulation of AHN, with important effects on cognitive plasticity and emotional flexibility. Since physical exercise (PE) is known to enhance neurotrophic factor levels, we hypothesised that PE could engage with cannabinoids to influence AHN and that this would result in beneficial effects under stressful conditions. We therefore investigated the actions of modulating cannabinoid type 2 receptors (CB2R), which are devoid of psychotropic effects, in combination with PE in chronically stressed animals. We found that CB2R inhibition, but not CB2R activation, in combination with PE significantly ameliorated stress-evoked emotional changes and cognitive deficits. Importantly, this combined strategy critically shaped stress-induced changes in AHN dynamics, leading to a significant increase in the rates of cell proliferation and differentiation of newborn neurons, overall reduction in neuroinflammation, and increased hippocampal levels of BDNF. Together, these results show that CB2Rs are crucial regulators of the beneficial effects of PE in countering the effects of chronic stress. Our work emphasises the importance of understanding the mechanisms behind the actions of cannabinoids and PE and provides a framework for future therapeutic strategies to treat stress-related disorders that capitalise on lifestyle interventions complemented with endocannabinoid pharmacomodulation.
© 2024. The Author(s).
Similar articles
-
Brain-Derived Neurotrophic Factor (BDNF) Role in Cannabinoid-Mediated Neurogenesis.Front Cell Neurosci. 2018 Nov 28;12:441. doi: 10.3389/fncel.2018.00441. eCollection 2018.PMID: 30546297 Free PMC article.
-
Cannabinoid type 2 receptors play a crucial role in social defeat-induced depression.J Affect Disord. 2024 Mar 1;348:333-344. doi: 10.1016/j.jad.2023.12.089. Epub 2024 Jan 1.PMID: 38171418
-
Electrophysiological Phenotypes of Hippocampal Synaptic and Network Functions in Cannabinoid Receptor 2 Knockout Mice.Cannabis Cannabinoid Res. 2024 Jan 22. doi: 10.1089/can.2023.0186. Online ahead of print.PMID: 38502778
-
Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases.Eur J Pharmacol. 2021 Oct 15;909:174398. doi: 10.1016/j.ejphar.2021.174398. Epub 2021 Jul 29.PMID: 34332924 Review.
-
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders.Front Psychiatry. 2022 Jun 14;13:828895. doi: 10.3389/fpsyt.2022.828895. eCollection 2022.PMID: 35774086 Free PMC article. Review.
References
-
- James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858. – DOI
-
- Kraus C, Kadriu B, Lanzenberger R, Zarate CA, Kasper S. Prognosis and improved outcomes in major depression: a review. Transl Psychiatry. 2019;9:1. 2019;9:1–17 – DOI